Cannabics Pharmaceuticals, Inc.
(Other OTC/NBB : CNBX)

( )
CNBX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. -1.54%74.761.0%$1946.65m
AMGNAmgen, Inc. -2.76%202.731.3%$903.34m
REGNRegeneron Pharmaceuticals, Inc. 3.23%488.292.6%$833.80m
BIIBBiogen, Inc. 0.08%316.381.5%$759.21m
VRTXVertex Pharmaceuticals, Inc. 2.60%237.951.9%$588.30m
MRNAModerna, Inc. -1.74%29.950.0%$535.64m
ILMNIllumina, Inc. -1.13%273.123.5%$472.24m
ALXNAlexion Pharmaceuticals, Inc. 2.90%89.792.0%$286.04m
AAgilent Technologies, Inc. -1.50%71.581.6%$228.47m
EXASEXACT Sciences Corp. -0.74%58.0021.0%$194.38m
INCYIncyte Corp. 1.47%73.232.5%$176.59m
SGENSeattle Genetics, Inc. 0.08%115.386.1%$169.50m
BMRNBioMarin Pharmaceutical, Inc. 2.44%84.504.3%$166.37m
NVAXNovavax, Inc. -5.04%13.58114.7%$124.83m
ALNYAlnylam Pharmaceuticals, Inc. 0.02%108.858.7%$102.43m

Company Profile

Cannabics Pharmaceuticals, Inc. is an early stage biotechnology company, which engages in the development of personalized anti-cancer and palliative treatments. It focuses on the research and development of cannabinoid-based diagnostics, anti-cancer pharmaceuticals, and palliative therapies. The company was founded by Itamar Borochov, Eyal Ballan, and Eyal Barad on September 15, 2004 and is headquartered in Bethesda, MD.